Skip to main content
. 2022 Feb 23;12:3074. doi: 10.1038/s41598-022-05164-4

Figure 7.

Figure 7

miR-298 treatment’s effect on APP and BACE1 proteins depends on the intrinsic property of each cell type and possible scenarios. (a) Western blot of APP and β-actin proteins. (b) Densitometry analysis. Each symbol represents a different group. (c) Schematic display of potential ways of regulation on APP mRNA 3′-UTR. The miR-298 binding sites on APP 3′-UTR are located downstream of miR-101. Several scenarios that lead to truncated 3′-UTR and could interfere miR-298 binding include alternative polyadenylation sites, presence of SNPs, mutations in miR-298 binding sites and cis-acting elements. Results of pairwise comparison of all treatments is shown by symbols. Treatments sharing a symbol did not significantly differ (p < 0.05). "(ns)" indicates no significant pairwise differences.